February / March #79 : The Baby Boon - by Esther Kaplan

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Archives » POZ Magazine issues

Table of Contents

A Loving Spoonful

Beat the Devil

Drug Bust

Southern Discomfort

The Baby Boon

Say What?

Fund 'n' Games

Hyde and Seek


Bar None

Test and Tell

Bike Drama


Mighty Reels

Dramatic Exit

Buzz Back From ICAAC

7/7 Heaven

Crib Notes

Garlic Press


The Love Bug

A Boy's Own Story

Publisher's Letter



Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

email print

February / March 2002

The Baby Boon

by Esther Kaplan

HIV positive South African Sisiwe Maqungo, 29, lost her daughter Nomazizi to AIDS when the child was only 9 months old. During the pregnancy, Maqungo didn't know her own HIV status, and her local Cape Town clinic offered neither tests nor drugs with which to help prevent transmission. It was only after bringing her ailing infant daughter to the hospital again and again that mother and child finally got HIV tests -- and diagnoses. When Nomazizi died two years ago, Maqungo said, "I made a promise to her that I would fight."

Maqungo soon joined the Treatment Action Campaign (TAC), the South African organization that fights for AIDS drug access. On December 14, TAC scored a major victory in its four-year campaign for nevirapine (Viramune) access for pregnant women when Justice Chris Botha of the Pretoria High Court found that "a countrywide MTCT [mother-to-child transmission] prevention program is an ineluctable obligation of the state" and directed the government (under anti-med stalwart President Thabo Mbeki) to present a plan by March 31. When she heard the news, Maqungo said. "I couldn't hold back the tears." One nevirapine dose for the mother during labor plus one dose for the newborn have been shown to cut transmission rates by 42 percent.

TAC's deputy chairperson, Sipho Mthathi, called the decision "a vindication of the rights of women to dignity and health care, and of children's right to life." The South African government already runs 18 pilot sites that provide counseling, HIV testing, nevirapine and formula to expectant mothers who need it, but Health Minister Manto Tshabalala-Msimang has long opposed going national with the program, citing prohibitive costs, drug toxicity and inadequate access to clean water for formula feeding. Haroon Saloojee, MD, who organized 250 docs and pediatricians to support TAC's suit, said none of the government's objections stand up. With approximately 200 infants infected daily, the $12 million price tag of a national program, he said, "still works out as a net gain compared with the cost of treating HIV positive children." A South African study of 2,000 infants showed the only side effect of a standard dose to be a skin rash. Lastly, two African studies have shown that even with breast-feeding, the advantages of nevirapine continued for up to 18 months.

Still, the battle is not over: Tshabalala-Msimang has promised to appeal the decision, expressing concern that the judgment "could have far-reaching implications...in shaping the state's responsibility for the delivery of social services." She softened the blow by calling for a "broader stakeholder discussion" in January, and insisted that the appeal would not stand in the way of developing an MTCT plan.

Saloojee is confident that TAC will win the appeal and called the stakeholder discussion "a smoke screen." He suspects that the government has taken such a hard-line stance because "they recognize that the demands won't end here -- the next step is to provide antiretrovirals for the mothers and fathers."

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Did you participate in an event for National Black HIV/AIDS Awareness Day 2016?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.